Role of Lamin A and emerin in maintaining nuclear morphology in different subtypes of ovarian epithelial cancer

Watabe,Shiori; Kobayashi,Sayaka; Hatori,Mizuho; Nishijima,Yoshimi; Inoue,Naoki; Ikota,Hayato; Iwase,Akira; Yokoo,Hideaki; Saio,Masanao

doi:10.3892/ol.2021.13127

Role of Lamin A and emerin in maintaining nuclear morphology in different subtypes of ovarian epithelial cancer

Authors:
- Shiori Watabe
- Sayaka Kobayashi
- Mizuho Hatori
- Yoshimi Nishijima
- Naoki Inoue
- Hayato Ikota
- Akira Iwase
- Hideaki Yokoo
- Masanao Saio
View Affiliations

Affiliations: Laboratory of Histopathology and Cytopathology, Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma 371‑8514, Japan, Department of Obstetrics and Gynecology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371‑8511, Japan, Clinical Department of Pathology, Gunma University Hospital, Maebashi, Gunma 371‑8511, Japan, Department of Human Pathology, Gunma University Graduate School of Medicine, Maebashi, Gunma 371‑8511, Japan
Published online on: November 9, 2021 https://doi.org/10.3892/ol.2021.13127
Article Number: 9
Copyright: © Watabe et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The nuclear lamina protein, Lamin A and inner nuclear membrane protein, emerin participate in maintaining nuclear morphology. However, their correlations with the nuclear shape in the four representative ovarian epithelial cancer subtypes, high‑grade serous carcinoma (HGSCa), clear cell carcinoma (CCCa), endometrioid carcinoma (EMCa) and mucinous carcinoma (MUCa), remains unclear. The present study aimed to investigate the association between nuclear morphology and nuclear membrane protein expression in four histological subtypes of ovarian epithelial cancer. A total of 140 surgically resected ovarian cancer specimens were subjected to Feulgen staining to evaluate nuclear morphology, and immunohistochemistry analysis to assess Lamin A and emerin expression. The histological images were analyzed via computer‑assisted image analysis (CAIA). The results demonstrated that the mean nuclear area of EMCa was significantly smaller compared with CCCa (P=0.0009). The standard deviation of the mean nuclear area was used to assess nuclear size variation, and the results indicated that EMCa lesions were significantly smaller than CCCa lesions (P=0.0006). Regarding the correlation between the Lamin A‑positive rate and nuclear morphological factors, positive correlations were observed with nuclear area in CCCa and EMCa (R=0.2855 and R=0.2858, respectively) and nuclear perimeter in CCCa, EMCa and MUCa (R=0.2409, R=0.4054 and R=0.2370, respectively); however, a negative correlation with nuclear shape factor was observed in HGSCa and EMCa (R=‑0.2079 and R=‑0.3707, respectively). With regards to the correlation between emerin positivity and nuclear morphological factors, positive correlations were observed with nuclear shape factor in HGSCa (R=0.2673) and nuclear area in CCCa (R=0.3310). It is well‑known that HGSCa and CCCa have conspicuous nuclear size variation, and EMCa has small nuclei without strong atypia. These findings were verified in the present study via CAIA. Taken together, the results of the present study suggest that Lamin A strongly contributes to the maintenance of nuclear morphology in ovarian epithelial cancer compared with emerin, although their contributions differ based on tumor subtype.

View Figures

View References

1	Chow KH, Factor RE and Ullman KS: The nuclear envelope environment and its cancer connections. Nat Rev Cancer. 12:196–209. 2012. View Article : Google Scholar : PubMed/NCBI
2	Fischer EG: Nuclear morphology and the biology of cancer cells. Acta Cytol. 64:511–519. 2020. View Article : Google Scholar : PubMed/NCBI
3	Burla R, La Torre M, Maccaroni K, Verni F, Giunta S and Saggio I: Interplay of the nuclear envelope with chromatin in physiology and pathology. Nucleus. 11:205–218. 2020. View Article : Google Scholar : PubMed/NCBI
4	Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG and Lee RT: Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem. 281:25768–25780. 2006. View Article : Google Scholar : PubMed/NCBI
5	Koch AJ and Holaska JM: Emerin in health and disease. Semin Cell Dev Biol. 29:95–106. 2014. View Article : Google Scholar : PubMed/NCBI
6	Lammerding J, Hsiao J, Schulze PC, Kozlov S, Stewart CL and Lee RT: Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol. 170:781–791. 2005. View Article : Google Scholar : PubMed/NCBI
7	Zink D, Fischer AH and Nickerson JA: Nuclear structure in cancer cells. Nat Rev Cancer. 4:677–687. 2004. View Article : Google Scholar : PubMed/NCBI
8	Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS and Ramaekers FC: Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol. 143:211–220. 1993.PubMed/NCBI
9	Machida H, Matsuo K, Yamagami W, Ebina Y, Kobayashi Y, Tabata T, Kanauchi M, Nagase S, Enomoto T and Mikami M: Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study. Gynecol Oncol. 153:589–596. 2019. View Article : Google Scholar : PubMed/NCBI
10	Peres LC, Cushing-Haugen KL, Köbel M, Harris HR, Berchuck A, Rossing MA, Schildkraut JM and Doherty JA: Invasive epithelial ovarian cancer survival by histotype and disease stage. J Natl Cancer Inst. 111:60–68. 2019. View Article : Google Scholar : PubMed/NCBI
11	Soslow RA: Histologic subtypes of ovarian carcinoma: An overview. Int J Gynecol Pathol. 27:161–174. 2008.PubMed/NCBI
12	Capo-chichi CD, Cai KQ, Simpkins F, Ganjei-Azar P, Godwin AK and Xu XX: Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med. 9:282011. View Article : Google Scholar : PubMed/NCBI
13	Capo-chichi CD, Cai KQ, Testa JR, Godwin AK and Xu XX: Loss of GATA6 leads to nuclear deformation and aneuploidy in ovarian cancer. Mol Cell Biol. 29:4766–4777. 2009. View Article : Google Scholar : PubMed/NCBI
14	Gong G, Chen P, Li L, Tan H, Zhou J, Zhou Y, Yang X and Wu X: Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis. Pathol Res Pract. 211:175–182. 2015. View Article : Google Scholar : PubMed/NCBI
15	Denny L: Ovarian fallopian tube, and primary peritoneal carcinoma. TNM Classification of Malignant Tumours. Brierley J, Gospodarowicz M and Wittekinnd C: Wiley Blackwell; Chichester: pp. 179–184. 2017
16	Varga VS, Ficsor L, Kamarás V, Jónás V, Virág T, Tulassay Z and Molnár B: Automated multichannel fluorescent whole slide imaging and its application for cytometry. Cytometry A. 75:1020–1030. 2009. View Article : Google Scholar : PubMed/NCBI
17	Guilford J: Correlation. In: Fundamental Statistics in Psychology and Education. Morgan C: McGraw-Hill Book Company; New York, NY: pp. 152–173. 1950
18	Rambau PF, Vierkant RA, Intermaggio MP, Kelemen LE, Goodman MT, Herpel E, Pharoah PD, Kommoss S, Jimenez-Linan M, Karlan BY, et al AOCS Group, : Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: An Ovarian Tumor Tissue Analysis consortium study. J Pathol Clin Res. 4:250–261. 2018. View Article : Google Scholar : PubMed/NCBI
19	Köbel M, Kalloger SE, Huntsman DG, Santos JL, Swenerton KD, Seidman JD, Gilks CB; Cheryl Brown Ovarian Cancer Outcomes Unit of the British Columbia Cancer Agency, ; Vancouver BC: Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol. 29:203–211. 2010. View Article : Google Scholar : PubMed/NCBI
20	Kyo S, Ishikawa N, Nakamura K and Nakayama K: The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies. Cancer Med. 9:421–431. 2020. View Article : Google Scholar : PubMed/NCBI
21	Soslow RA, Brenton JD, Davidson B, Folkins AK, Kong CS, Malpica A, Soerjomataram I and Vang R: High-grade serous carcinoma of the ovary. Female genital tumours, WHO classification of tumours. Cheung AN, Ellenson LH and Gilks CB: International Agency for Research on Cancer; Lyon: pp. 45–47. 2019
22	Seidman JD, Ronnett BM, Shih IM, Cho KR and Kurman RJ: Epithelial tumors of the ovary. Blausteins's pathology of the female genital tract. Kurman RJ, Ellenson LH and Ronnett BM: Springer; Berlin: pp. 841–966. 2019, View Article : Google Scholar
23	Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM and Silva EG: Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 28:496–504. 2004. View Article : Google Scholar : PubMed/NCBI
24	Vang R, Shih IeM and Kurman RJ: Ovarian low-grade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 16:267–282. 2009. View Article : Google Scholar : PubMed/NCBI
25	Ramalingam P: Morphologic, immunophenotypic, and molecular features of epithelial ovarian cancer. Oncology (Williston Park). 30:166–176. 2016.PubMed/NCBI
26	Kobel M, Hunstman DG, Lim D, McCluggage WG, Rabban JT and Shih I: Endometrioid carcinoma of the ovary. Female Genital Tumours, WHO Classification of Tumours. Cheung AN, Ellenson LH and Gilks CB: International Agency for Research on Cancer; Lyon: pp. 58–61. 2019
27	Kobel M, Bennett JA, Cheung AN, DeLair DF, Kiyokawa T and Shih I: Clear cell carcinoma of the ovary. Female Genital Tumours, WHO Classification of Tumours. Cheung AN, Ellenson LH and Gilks CB: International Agency for Research on Cancer; Lyon: pp. 65–67. 2019
28	Zeimet AG, Fiegl H, Goebel G, Kopp F, Allasia C, Reimer D, Steppan I, Mueller-Holzner E, Ehrlich M and Marth C: DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer. Gynecol Oncol. 121:24–31. 2011. View Article : Google Scholar : PubMed/NCBI
29	Rodríguez IM and Prat J: Mucinous tumors of the ovary: A clinicopathologic analysis of 75 borderline tumors (of intestinal type) and carcinomas. Am J Surg Pathol. 26:139–152. 2002. View Article : Google Scholar : PubMed/NCBI
30	Capo-chichi CD, Cai KQ, Smedberg J, Ganjei-Azar P, Godwin AK and Xu XX: Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin J Cancer. 30:415–425. 2011. View Article : Google Scholar : PubMed/NCBI
31	Kim JK, Louhghalam A, Lee G, Schafer BW, Wirtz D and Kim DH: Nuclear lamin A/C harnesses the perinuclear apical actin cables to protect nuclear morphology. Nat Commun. 8:21232017. View Article : Google Scholar : PubMed/NCBI
32	Smith ER, Meng Y, Moore R, Tse JD, Xu AG and Xu XX: Nuclear envelope structural proteins facilitate nuclear shape changes accompanying embryonic differentiation and fidelity of gene expression. BMC Cell Biol. 18:82017. View Article : Google Scholar : PubMed/NCBI
33	Jevtić P, Edens LJ, Li X, Nguyen T, Chen P and Levy DL: Concentration-dependent effects of nuclear lamins on nuclear size in Xenopus and mammalian cells. J Biol Chem. 290:27557–27571. 2015. View Article : Google Scholar : PubMed/NCBI
34	Liddane AG, McNamara CA, Campbell MC, Mercier I and Holaska JM: Defects in emerin-nucleoskeleton binding disrupt nuclear structure and promote breast cancer cell motility and metastasis. Mol Cancer Res. 19:1196–1207. 2021. View Article : Google Scholar : PubMed/NCBI